10 min listen
ACCEL Lite: ESC Late Breaker: MASTER DAPT
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ACCEL Lite: ESC Late Breaker: MASTER DAPT
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
12 minutes
Released:
Sep 28, 2021
Format:
Podcast episode
Description
This large, multicentre, randomized trial was conducted with patients at high risk for bleeding who had undergone biodegradable polymer sirolimus-eluting stent implantation to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events. And if so, whether it mitigates major or nonmajor clinically relevant bleeding occurrences, compared with longer treatment durations. In this episode, Prof Marco Valgimigli, MD, PhD, FESC and Poonam Velagapudi MD, MS discuss ESC Late Breaker: MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients. Like what you hear? Get 20 episodes/month with CME/MOC credit! www.acc.org/ACCEL
Released:
Sep 28, 2021
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: Asymptomatic Severe AS; Outcomes of Early Intervention: In this interview, Spencer King III, MD, MACC; Michael Reardon, MD; and Michelle Kelsey, MD, discuss the natural history of asymptomatic severe aortic stenosis and the association of early intervention with outcomes. For 20+ insider interviews like... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research